Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Partnership coming or not? No one believes cancer news…
View:
Post by Dcutter101 on Nov 22, 2021 12:59pm

Partnership coming or not? No one believes cancer news…

So let's Get NASH going!!!
Comment by Wino115 on Nov 22, 2021 3:57pm
I thought about the selling pressure too, but came to the conclusion that given the highly conservative nature of management, the fact most are remote still, and the fact we analyze every darn clue there is released or not, that I just don't think there is any group of investors that knows a whole lot more than we do about the cancer opportunity.  So I discount that someone has ferreted ...more  
Comment by palinc2000 on Nov 22, 2021 4:45pm
Wino From the beginning you have mentionrd a time line of a year or so to conclude a partnership deal for Nash....This assumption sort of means that you think that Paul is wet behind the ears when it comes to deal making .....Paul has never even hinted at such a long timeline. Maybe your theory is based on the premise that Thtx would start Phase 3 all on their own while still carrying a search ...more  
Comment by SPCEO1 on Nov 22, 2021 6:41pm
In the Credit Suisse presentation he did comment about how well aware he is of how slow a large pharma company is in such matters because of all the levels of approval a deal needs to get in the large company bureacracy. The noises I have heard from the beginning on partnerring Egrifta in NASH have never made me think there is 2 or three competitors chomping at the bit. They are going to need to ...more  
Comment by qwerty22 on Nov 22, 2021 7:16pm
Imagine if in early 2019 they'd decided to dose 100 F2/F3, non-HIV,, biopsied. Started dosing early 2020. We'd be awaited a 1 year readout in a Q or two. The ugly duckling would be becoming a swan (or being put down). That would be something to look forward to. [/quote]
Comment by Wino115 on Nov 22, 2021 7:56pm
I've stated from day 1 it is a 6 month minimum, 12 month maximum to pitch, structure, sign an actual deal. So maybe it's 6, maybe 12, but no sooner than 6.  We are 3 months are so into that at this point.  The reason being that I do think there will be interest, but that to commit a mid-to-large pharma will take time to get behind the science, then you have the financial side of ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse